Invasive Fungal Sinusitis
On this page
Direct answer
Invasive fungal sinusitis is a life-threatening angioinvasive infection — mucormycosis (Rhizopus and related Mucorales) or invasive aspergillosis — that strikes immunocompromised hosts: uncontrolled diabetes with ketoacidosis above all, plus neutropenia, transplant immunosuppression and the steroid-heavy COVID-19 course India witnessed in 2021. Fungal hyphae invade nasal mucosal vessels, infarct tissue, and spread from nose and sinuses into the orbit and brain, so the earliest signs are facial pain or numbness, nasal congestion and fever, followed by the pathognomonic black eschar on the turbinate or palate, orbital swelling with vision loss, and cranial nerve palsies. Diagnosis is clinical plus urgent biopsy, and treatment combines aggressive surgical debridement with liposomal amphotericin B and rapid reversal of the underlying immune defect — any delay is measured in days of survival.
What you must remember
- Forms to classify: acute invasive fungal rhinosinusitis (days, angioinvasive, Mucorales), chronic invasive and chronic granulomatous invasive forms (months, Aspergillus — the granulomatous type classically described in immunocompetent Sudanese and North Indian patients) — contrasted with non-invasive allergic fungal sinusitis and mycetoma.
- The host, not the fungus, decides: diabetic ketoacidosis, haematological malignancy with neutropenia, post-transplant steroids, and high-dose steroid plus diabetes during severe COVID-19 — the 2021 mucormycosis epidemic in India followed exactly that combination.
- Early signs on examination: unilateral facial or dental pain, cheek or periorbital swelling, diplopia or falling vision, nasal septal or turbinate necrosis; anaesthesia of the cheek or palate (vascular infarction of the trigeminal branches) precedes obvious necrosis — painless ulceration is a red flag, not reassurance.
- Black eschar: devitalised, insensitive mucosa on the middle turbinate, septum or hard palate — biopsy shows broad, ribbon-like, pauciseptate hyphae with right-angle branching (Mucorales) versus narrower septate hyphae with acute-angle branching (Aspergillus).
- Imaging: contrast computed tomography of paranasal sinuses defines extent — orbital apical involvement, pterygopalatine fossa, skull base, cavernous sinus; magnetic resonance imaging for intracranial and orbital spread; mucosal thickening alone on imaging never excludes early invasion — biopsy outranks scans.
- Treatment triplet: urgent extensive surgical debridement (endoscopic, often staged, sometimes orbital exenteration in advanced orbit disease), liposomal amphotericin B at induction doses with renal monitoring (posaconazole or isavuconazole as step-down/alternative), and iron control — deferoxamine is contraindicated as it feeds Mucorales — plus rigid glycaemic control and steroid weaning.
- Mortality: acute invasive disease, particularly rhino-orbito-cerebral mucormycosis, still kills a large fraction even with optimal care; survival correlates directly with speed of debridement and immune reconstitution.
A diabetic emergency worked through
A 54-year-old diabetic presents with five days of left cheek pain, nasal blockage and blurred vision; glucose 420 mg/dL with ketones. Within the hour comes nasal endoscopy: a black, insensate eschar on the left middle turbinate is biopsied, showing broad pauciseptate ribbon-like hyphae, and contrast computed tomography shows maxillary and ethmoid opacification reaching the orbital apex.
Management runs on parallel rails: insulin infusion and electrolyte correction for the ketoacidosis, first-dose liposomal amphotericin B the same day, and staged endoscopic debridement — unroofing the orbit, clearing necrotic turbinate, septum and sinus mucosa until healthy bleeding tissue is reached, re-debriding every few days. Daily ophthalmology review tracks vision; any progression despite surgery and amphotericin prompts wider resection, and cerebral extension carries a grave prognosis. With a three-month proptosis in an immunocompetent host instead, the diagnosis shifts to chronic granulomatous invasive aspergillosis — slower, still surgical, with long-term antifungals. The discipline in every variant: endoscopy early, biopsy early, debride early.
Where examiners dig
The viva hinges on distinctions. Invasive versus allergic fungal sinusitis: allergic disease fills the sinus with inspissated eosinophilic mucin containing fungal elements without tissue invasion, occurs in atopic immunocompetent patients, and responds to steroids and surgery — a completely different disease from the angioinvasive emergency. Mucorales versus Aspergillus on histology: broad ribbon-like pauciseptate hyphae with right-angle branching versus narrow septate acute-angle branching — the standard drawing every candidate must produce. The third favourite is the Indian context: the COVID-19-associated mucormycosis surge of 2021, when uncontrolled diabetes, high-dose steroids and the virus converged — a public-health question as much as a microbiological one.
Frequently asked questions
Which patients develop acute invasive fungal sinusitis?
Immunocompromised hosts — above all uncontrolled diabetics in ketoacidosis, but also neutropenic, post-transplant and high-dose steroid patients, including severe COVID-19 with diabetes.
What is the significance of a black eschar in the nose?
It is infarcted, angioinvasion-devitalised mucosa — painless because nerves are infarcted too — and biopsy confirming hyphae makes invasive fungal sinusitis a surgical emergency.
How are Mucorales distinguished from Aspergillus histologically?
Mucorales are broad, ribbon-like and pauciseptate with right-angle branching; Aspergillus shows narrow, regular septate hyphae branching at acute angles.
What is the treatment of rhino-orbito-cerebral mucormycosis?
Urgent aggressive surgical debridement plus liposomal amphotericin B, with rigorous correction of diabetic ketoacidosis and withdrawal of immunosuppression; posaconazole or isavuconazole for step-down or salvage.
How does allergic fungal sinusitis differ from invasive disease?
Allergic fungal sinusitis is a non-invasive eosinophilic mucin disease of atopic patients without tissue invasion, treated by surgical clearance and corticosteroids rather than antifungals and emergency debridement.